We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 10

Criminal and related antitrust developments in 2012: Canada and the world

  • Fasken Martineau DuMoulin LLP
  • -
  • Australia, Canada, China, European Union, India, Japan, New Zealand, South Korea, United Kingdom, USA
  • -
  • April 2 2013

This article outlines the major global criminal and related antitrust developments in 2012, with a focus on Canada. Three salient realities

Bribery laws: protecting your good name

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, United Kingdom, USA
  • -
  • April 19 2012

As the corporate risk landscape changes, companies need to conduct a risk assessment and implement a top-down culture and compliance program against bribery and corruption

Canada-UK Patent Prosecution Highway pilot programme launches

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, United Kingdom
  • -
  • March 7 2012

The Patent Prosecution Highway pilot project between the Canadian Intellectual Property Office and the UK Intellectual Property Office has taken effect for a two-year period

Bribery laws: protecting your good name part II - litigators

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, United Kingdom, USA
  • -
  • March 1 2012

As the corporate risk landscape changes, North American companies need to conduct a risk assessment and implement a top-down culture and compliance program against bribery and corruption

Bribery laws: protecting your good name. Part I - corporate legal counsel

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, United Kingdom, USA
  • -
  • February 16 2012

As the corporate risk landscape changes, North American companies need to conduct a risk assessment and implement a top-down culture and compliance program against bribery and corruption

AIM Designated Market route

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, United Kingdom
  • -
  • January 12 2012

To encourage smaller growing companies that already trade on other markets to be listed on AIM, AIM offers the AIM Designated Market route (formerly called the Fast Track route), which is a streamlined admission process available to companies that have had their securities traded on an AIM Designated Market ("ADM") for at least 18 months prior to the date of admission to AIM

Spam and cookies: legal obligations on unsolicited electronic mail and cookies in the UK (Europe) and Canada

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, European Union, United Kingdom
  • -
  • August 10 2011

In 2002 the EU issued the Privacy and Electronic Communications Directive (200258EC), which covers the sending of unsolicited commercial email

High Court sets aside £17.5m cross-undertaking in damages award

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, United Kingdom
  • -
  • April 14 2011

The award of £17.5 million damages to Apotex under a cross-undertaking in damages given by Servier has been set aside by the High Court on the basis of public policy and the rule of law that no action can arise from an illegal or immoral act here the manufacture of a generic medicine that infringed a valid foreign patent

Exemptions from financial reporting aspects of the EU Transparency Directive

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, United Kingdom
  • -
  • October 29 2010

This Bulletin is of direct relevance to public companies having registered offices in Canada, listing or intending to list their securities on a UK regulated market

Bribery and corruption in international business

  • Fasken Martineau DuMoulin LLP
  • -
  • Canada, United Kingdom, USA
  • -
  • April 23 2010

This is a business brief in three parts

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy